China's National Health Commission has said COVID-19 vaccines could complete their second-phase clinical trials as early as July.Speaking at a news conference on Friday, its vice minister said the trials so far had been successful.(SOUNDBITE) (Mandarin) NATIONAL HEALTH COMMISSION VICE MINISTER, ZENG YIXIN, SAYING:"During the clinical trials of these projects, as of now, we haven't…
As much of the world remains at home due to the coronavirus, a lot of people have put their hopes of a big economic reopening on a vaccine. With more than 100 vaccine candidates for Covid-19 in production, things seem to be looking up — and the conventional wisdom, often restated by White House officials,…
Experts are hopeful that a vaccine against the SARS-CoV-2 virus will become available sooner rather than later. SOPA Images/Getty Images For the most up-to-date news and information about the coronavirus pandemic, visit the WHO website. As the death toll from the novel coronavirus nears 300,000 worldwide, doctors and scientists are scrambling to develop multiple vaccines to stop…
A researcher of the Openlab genetic and cell technologies laboratory of the Kazan Federal University working with biomaterial.Yegor Aleyev | TASS via Getty ImagesHealth officials and scientists across the world are racing to develop vaccines and discover effective treatments against the coronavirus, which has infected more than 4.2 million people worldwide in as little as…
By Layal Liverpool BCG vaccine (red, lower left) infecting a human white blood cell (green)NIBSC/SCIENCE PHOTO LIBRARY The BCG (Bacillus Calmette-Guérin) tuberculosis vaccine boosts the production of immune cells, which may explain why it can protect newborn babies from dying of sepsis. Previous studies have shown that BCG vaccination can protect newborns against a broad…
6 min read Long gone are the days when cheating was as easy to spot as a lipstick smudge on a shirt collar. In 2026, infidelity often takes the smaller, yet nonetheless shitty, form of “microcheating.” It could be a borderline flirty text to a colleague or check-ins with an old “friend” that start out
You don't have permission to access "http://www.medpagetoday.com/transplantation/hearttransplantation/119412" on this server. Reference #18.8a1c1602.1768366940.7e14c81d https://errors.edgesuite.net/18.8a1c1602.1768366940.7e14c81d
4 min read A new study found people lost an average of 32.4 pounds while on semaglutide and tirzepatide. People who discontinue GLP-1 drugs regained nearly 22 pounds within a year. They returned to their starting weight in less than 2 years. Doctors say there's three common mistakes people make that is likely contributing to